Keyphrases
Disease Progression
100%
L-DOPA
100%
Carotid Intima-media Thickness (cIMT)
100%
Homocysteine Levels
100%
Neuropsychiatric Complications
100%
Parkinson's Disease
100%
Homocysteine
60%
Disease Severity
40%
Non-associated
40%
Disease Duration
40%
Psychosis
40%
Parkinson Patients
40%
Patients with Parkinson's Disease
40%
Elevated Homocysteine Levels
40%
Rating Scales
20%
Dementia
20%
Cognitive Performance
20%
Cognitive Function
20%
Blood Samples
20%
Frontal Assessment Battery
20%
Common Carotid Artery
20%
Psychiatric Manifestations
20%
Treatment Duration
20%
Neuropsychiatric Features
20%
Frontal Lobe Epilepsy
20%
Idiopathic Parkinson's Disease
20%
Unified Parkinson's Disease Rating Scale (UPDRS)
20%
Vascular Disease
20%
Cardiovascular Comorbidities
20%
Vascular Depression
20%
B-mode Ultrasound
20%
Cognitive Decline
20%
Clinical Characteristics
20%
Vascular Dementia
20%
Mini-Mental State Examination
20%
Intima-media Thickness
20%
Beck Depression inventory-II (BDI-II)
20%
Cardiovascular Morbidity
20%
Vascular Comorbidity
20%
Parkinson's Disease Psychosis
20%
Hyperhomocystinemia
20%
Enhanced Respiratory Disease
20%
Medicine and Dentistry
Disease Exacerbation
100%
Homocysteine
100%
Intima-Media Thickness
100%
Parkinson's Disease
100%
Cardiovascular System
20%
Disease Severity
20%
Disease Duration
20%
Mental Health
10%
Rating Scale
10%
Cognition
10%
Unified Parkinson's Disease Rating Scale
10%
Vascular Dementia
10%
Common Carotid Artery
10%
Treatment Duration
10%
Atherosclerosis
10%
Beck Depression Inventory
10%
Frontal Lobe
10%
Vascular Disease
10%
Pharmacology, Toxicology and Pharmaceutical Science
Homocysteine
100%
Disease Exacerbation
100%
Parkinson's Disease
100%
Comorbidity
20%
Disease Severity
20%
Disease Duration
20%
Atherosclerosis
10%
Multiinfarct Dementia
10%
Vascular Disease
10%
Neuroscience
Parkinson's Disease
100%
Homocysteine
100%
Frontal Lobe
10%
Mental Status Examination
10%
Vascular Disease
10%
Beck Depression Inventory
10%
Cognitive Function
10%
Vascular Dementia
10%
Common Carotid Artery
10%